Cargando…
ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129721/ https://www.ncbi.nlm.nih.gov/pubmed/32283335 http://dx.doi.org/10.1016/j.jcv.2020.104350 |
| _version_ | 1783516849875451904 |
|---|---|
| author | Skarstein Kolberg, Espen |
| author_facet | Skarstein Kolberg, Espen |
| author_sort | Skarstein Kolberg, Espen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7129721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71297212020-04-08 ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease Skarstein Kolberg, Espen J Clin Virol Article Elsevier B.V. 2020-05 2020-04-02 /pmc/articles/PMC7129721/ /pubmed/32283335 http://dx.doi.org/10.1016/j.jcv.2020.104350 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Skarstein Kolberg, Espen ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title | ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title_full | ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title_fullStr | ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title_full_unstemmed | ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title_short | ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease |
| title_sort | ace2, covid19 and serum ace as a possible biomarker to predict severity of disease |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129721/ https://www.ncbi.nlm.nih.gov/pubmed/32283335 http://dx.doi.org/10.1016/j.jcv.2020.104350 |
| work_keys_str_mv | AT skarsteinkolbergespen ace2covid19andserumaceasapossiblebiomarkertopredictseverityofdisease |